Table 4.
Multivariable linear regression models evaluating the relationship of disease activity, represented by low DAS28ESR and CDAI at three sites: femoral neck, total hip and lumbar spine. All models control for the same variables in our primary model and were similarly weighted by number of study visits.
| Low DAS28ESR a,b | Low CDAI a,b | |||||
|---|---|---|---|---|---|---|
| β | 95% CI | p-value | β | 95% CI | p-value | |
| Femoral Neckc | 0.071 | 0.021 to 0.122 | 0.020 | 0.051 | 0.005 to 0.098 | 0.032 |
| Total Hipc | 0.071 | 0.021 to 0.122 | 0.006 | 0.085 | 0.038 to 0.132 | 0.001 |
| Lumbar Spinec | 0.060 | −0.004 to 0.124 | 0.067 | 0.057 | −0.005 to 0.118 | 0.069 |
-DAS28ESR: Disease activity score 28-joints with erythrocyte sedimentation rate; CDAI: clinical disease activity index; DXA: dual x-ray absorptiometry; RA: rheumatoid arthritis; anti-cyclic citrullinated peptide; bDMARD: biologic disease modifying anti-rheumatic drug; OP: osteoporosis; BMI: body mass index.
Low DAS28ESR DAS28ESR ≤3.2 vs. moderate/high DAS28ESR >3.2.; Low CDAI <10 vs. high/moderate ≥10.
Cumulative values calculated using trapezoidal area under the curve/observation time.
Controlled for: age at DXA, female sex, race/ethnicity, RA duration, BMI, bDMARD use, Prednisone dose, ACPA positivity and OP medication use.